603127.SH
昭衍新药
SSE · Healthcare · Medical - Diagnostics & Research · CN
CNY 46.39
−5.85%Aug 28, 2026, 08:55 UTC
Joinn Laboratories released its 2026 interim report on August 28, reporting net profit attributable to shareholders of 748 million yuan, up 1126.8% year-on-year, and revenue of 704 million yuan, up 5.27% year-on-year.
Source:Jul 15, 2026, 01:50 UTC
Joinn Laboratories (06127) issued a profit alert, expecting a significant increase in net profit for the first half of 2026 due to a rise in biological asset market prices.